Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06396819
Status:
COMPLETED
Last Update Posted:
2024-05-02
First Post:
2024-04-30
Brief Title:
Collagen-povidone for Diabetic Seniors Tenosynovitis
Sponsor:
Instituto Mexicano del Seguro Social
Organization:
Instituto Mexicano del Seguro Social
Study Overview
Official Title:
Topical Collagen-povidone Injection as an Alternative Treatment for Stenosing Tenosynovitis in Older Adults With Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Diabetes affects 415 million adults globally leading to hand issues Povidone collagen shows promise in managing tenosynovitis A clinical trial was conduced to compared its efficacy in adults over 60 It is shown that the intervention reduces pain improves functionality and grip strength with no complications Collagen povidone holds potential for treating diabetic hand issues
Detailed Description:
A randomized clinical trial from January 2022 to January 2023 compared povidone collagen intervention with a placebo in adults aged 60 and above suffering from stenosing tenosynovitis Participants were randomized into Case collagen-povidone and Control physiological solution groups The study evaluated parameters like tenosynovitis diabetes pain functionality and grip strength
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None